Infection related to deep brain stimulation in patients with Parkinson disease: Clinical characteristics and risk factors

J Neurol Sci. 2017 Dec 15:383:135-141. doi: 10.1016/j.jns.2017.10.031. Epub 2017 Oct 24.

Abstract

Objective: Risk factors of infection after deep brain stimulation (DBS) surgery in patients with Parkinson disease (PD) have been controversial. We aimed to investigate the clinical characteristics and risk factors of infection after DBS surgery in PD patients.

Methods: We retrospectively investigated 246 consecutive DBS surgeries in 169 advanced PD patients. Clinical data were collected and analyzed to clarify the clinical characteristics associated with infection after DBS surgery. Multivariate logistic regression analysis was used to assess risk factors for infection after DBS surgery.

Results: Infection occurred in 5% of all DBS surgeries and in 7% of all PD patients who received DBS surgery. Most infections (75%) occurred within 3months after DBS surgery but it also occurred 21months after DBS surgery. Gram-positive bacteria were the most common pathogens (75%). Infection after DBS surgery was associated with short period of prophylactic antibiotic therapy (OR=0.62, 95% CI=0.45-0.85, P=0.002) and intensive care unit (ICU) management immediate after DBS surgery (OR=5.43, 95% CI=1.12-26.45, P=0.036).

Conclusion: Our study suggests that short period of prophylactic antibiotic therapy and ICU management after surgery may increase the risk of infection in PD patients who received DBS surgery.

Keywords: Deep brain stimulation; Infection; Parkinson disease; Risk factors.

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Comorbidity
  • Critical Care
  • Deep Brain Stimulation / adverse effects*
  • Female
  • Humans
  • Incidence
  • Infections / drug therapy
  • Infections / epidemiology*
  • Infections / etiology*
  • Infections / physiopathology
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Parkinson Disease / complications
  • Parkinson Disease / epidemiology*
  • Parkinson Disease / physiopathology
  • Parkinson Disease / therapy*
  • Postoperative Complications / drug therapy
  • Postoperative Complications / epidemiology*
  • Postoperative Complications / physiopathology
  • Risk Factors

Substances

  • Anti-Bacterial Agents